Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 01 Sept 2026 for Avalo Therapeutics, Inc., €4,682.
Filing timeline
BuySaleMittie Doyle
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mittie Doyle: trading record in brief
All filings by Mittie Doyle on record concern Avalo Therapeutics, Inc. In total, 25 filings cover trades dated from 10 December 2025 to 28 August 2026.
On the market, this insider has only sold: 10 sales, €603k in total. Besides market trades, the filings include 3 share grants and 12 option exercises. So far in 2026, the count stands at no purchases and 10 sales.
The newest entry dates from 1 September 2026: an option exercise of €4,682, in Avalo Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mittie Doyle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
679 shares@ US$8.040.0005% mcap1.1% of flowCommon StockSEC:0001918845-26-000031:0
679 shares@ US$20.000.0013% mcap2.6% of flowCommon StockSEC:0001918845-26-000031:1
1,000 shares@ US$12.650.0012% mcap2.6% of flowCommon StockSEC:0001918845-26-000029:0
1,000 shares@ US$20.000.0019% mcap4.1% of flowCommon StockSEC:0001918845-26-000029:1
679 shares@ US$8.040.0005% mcap1.2% of flowCommon StockSEC:0001918845-26-000026:0
679 shares@ US$20.000.0013% mcap3.0% of flowCommon StockSEC:0001918845-26-000026:1
1,000 shares@ US$12.650.0012% mcap2.9% of flowCommon StockSEC:0001918845-26-000024:0
1,000 shares@ US$20.000.0019% mcap4.6% of flowCommon StockSEC:0001918845-26-000024:1
2,875 sharesCommon StockSEC:0001918845-26-000022:0
1,779 sharesCommon StockSEC:0001918845-26-000022:1
4,654 sharesCommon StockSEC:0001918845-26-000022:2
1,450 sharesCommon StockSEC:0001918845-26-000020:0
1,450 sharesCommon StockSEC:0001918845-26-000020:1
1,084 sharesCommon StockSEC:0001918845-26-000018:0
679 shares@ US$8.040.0005% mcap33.4% of flowCommon StockSEC:0001918845-26-000016:0
679 shares@ US$16.000.0010% mcap66.6% of flowCommon StockSEC:0001918845-26-000016:1
43,500 shares0Common StockSEC:0001918845-26-000014:0
3,970 shares@ US$18.012251.8% of flowCommon StockSEC:0001918845-26-000008:1
3,970 shares@ US$12.6536.4% of flowCommon StockSEC:0001918845-26-000008:0
679 shares@ US$8.043.5% of flowCommon StockSEC:0001918845-26-000006:0
679 shares@ US$16.007.0% of flowCommon StockSEC:0001918845-26-000006:1
19,500 shares@ US$12.6561.8% of flowCommon StockSEC:0001918845-26-000004:0
1,013 shares@ US$4.101.0% of flowCommon StockSEC:0001470831-25-000412:0
23 of 23 declarations
